Combines robotics, software and a library of validated reactions to design and make molecules on demand for pharma, biotech and materials companies.
Why they'll be hiring in 2027. Raised a Series B of more than $50m in October 2025 and listed 21 open roles in October 2026 across chemistry, engineering and software.